Literature DB >> 16189148

KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype.

A Carbone1, A Gloghini, E Vaccher, G Marchetti, G Gaidano, U Tirelli.   

Abstract

BACKGROUND: Kaposi sarcoma associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) associated lymphomas, which often develop in human immunodeficiency virus (HIV) infected patients with advanced AIDS, present predominantly as primary effusion lymphoma (PEL) or, less frequently, as "solid" extracavitary based lymphomas, associated with serous effusions. These last lymphomas, also called "solid PEL", have been reported before the development of an effusion lymphoma and after resolution of PEL. Interestingly, KSHV/HHV-8 associated lymphomas that present as solid or extracavitary based lesions in HIV seropositive patients without serous effusions have been reported recently. METHODS/
RESULTS: This paper provides evidence for the existence of a previously undescribed KSHV/HHV-8 associated lymphoma in HIV seronegative patients without serous effusions. These lymphomas exhibit a predilection for the lymph nodes and display anaplastic large cell morphology. These tumours were completely devoid of common cell type specific antigens, including epithelial and melanocytic cell markers. B and T cell associated antigens and other commonly used lymphoid markers were absent or weakly demonstrable in a fraction of the tumour cells. Conversely, immunohistochemical studies showed strong immunostaining with plasma cell reactive antibodies.
CONCLUSIONS: Analysis of viral infection and immunohistological studies are of primary importance to define this lymph node based KSHV/HHV-8 associated lymphoma with anaplastic large cell morphology and plasmablastic immunophenotype occurring in HIV seronegative patients without serous effusions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189148      PMCID: PMC1770735          DOI: 10.1136/jcp.2005.026542

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  45 in total

1.  Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.

Authors:  L Pan; L Milligan; J Michaeli; E Cesarman; D M Knowles
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

2.  Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology.

Authors:  H Katano; T Suda; Y Morishita; K Yamamoto; Y Hoshino; K Nakamura; N Tachikawa; T Sata; H Hamaguchi; A Iwamoto; S Mori
Journal:  Mod Pathol       Date:  2000-01       Impact factor: 7.842

3.  Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.

Authors:  Eric A Engels; Stefania Pittaluga; Denise Whitby; Charles Rabkin; Yoshiyasu Aoki; Elaine S Jaffe; James J Goedert
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

4.  Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient.

Authors:  P Morand; M Buisson; H Collandre; B Chanzy; O Genoulaz; M J Bourgeat; N Pinel; P Leclercq; D Leroux; V Marechal; L Fritsch; R Ruigrok; J M Seigneurin
Journal:  Leuk Lymphoma       Date:  1999-10

5.  Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.

Authors:  A Carbone; A Gloghini; L M Larocca; D Capello; F Pierconti; V Canzonieri; U Tirelli; R Dalla-Favera; G Gaidano
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

6.  High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

Authors:  E Oksenhendler; G Carcelain; Y Aoki; E Boulanger; A Maillard; J P Clauvel; F Agbalika
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

7.  Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions.

Authors:  A Carbone; A M Cilia; A Gloghini; V Canzonieri; C Pastore; M Todesco; M Cozzi; T Perin; R Volpe; A Pinto; G Gaidano
Journal:  Int J Cancer       Date:  1997-11-14       Impact factor: 7.396

8.  Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient.

Authors:  S Ariad; D Benharroch; L Lupu; B Davidovici; N Dupin; C Boshoff
Journal:  Arch Pathol Lab Med       Date:  2000-05       Impact factor: 5.534

9.  HHV-8- and EBV-associated nonepidermotrophic large B-cell lymphoma presenting as a foot rash in a man with AIDS.

Authors:  David M Aboulafia
Journal:  AIDS Patient Care STDS       Date:  2002-04       Impact factor: 5.078

10.  High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Authors:  Eric Oksenhendler; Emmanuelle Boulanger; Lionel Galicier; Ming-Qing Du; Nicolas Dupin; Tim C Diss; Rifat Hamoudi; Marie-Thérèse Daniel; Félix Agbalika; Chris Boshoff; Jean-Pierre Clauvel; Peter G Isaacson; Véronique Meignin
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

View more
  10 in total

Review 1.  KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: New Findings and Review of the Literature.

Authors:  Tapan Bhavsar; John C Lee; Yvonne Perner; Mark Raffeld; Liqiang Xi; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2017-06       Impact factor: 6.394

Review 2.  Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.

Authors:  William R Foster; Alina Bischin; Russell Dorer; David M Aboulafia
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-04-01

3.  Lymph node-based disease and HHV-8/KSHV infection in HIV seronegative patients: report of three new cases of a heterogeneous group of diseases.

Authors:  Antonio D'Antonio; Maria Addesso; Domenico Memoli; Pina Liguori; Roberto Cuomo; Amedeo Boscaino; Oscar Nappi
Journal:  Int J Hematol       Date:  2011-04-21       Impact factor: 2.490

4.  Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders.

Authors:  Massimo Granai; Mattia Facchetti; Virginia Mancini; Jacqueline Goedhals; Alicia Sherriff; Lucia Mundo; Cristiana Bellan; Teresa Amato; Ester Sorrentino; Marco Ungari; Martine Raphael; Lorenzo Leoncini; Fabio Facchetti; Stefano Lazzi
Journal:  Histopathology       Date:  2021-10-04       Impact factor: 7.778

5.  Viral studies in burkitt lymphoma: association with Epstein-Barr virus but not HHV-8.

Authors:  Eduardo M Queiroga; Gabriela Gualco; Lucimara Chioato; William J Harrington; Iguaracyra Araujo; Lawrence M Weiss; Carlos E Bacchi
Journal:  Am J Clin Pathol       Date:  2008-08       Impact factor: 2.493

Review 6.  Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

Authors:  M-Q Du; C M Bacon; P G Isaacson
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

7.  HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.

Authors:  Amy Chadburn; Jonathan Said; Dita Gratzinger; John K C Chan; Daphne de Jong; Elaine S Jaffe; Yasodha Natkunam; John R Goodlad
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

8.  Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study.

Authors:  Y Benavente; G Mbisa; N Labo; D Casabonne; N Becker; M Maynadie; L Foretova; P L Cocco; A Nieters; A Staines; P Bofetta; P Brennan; D Whitby; S de Sanjosé
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

9.  Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.

Authors:  Sanam Loghavi; Khaled Alayed; Tariq N Aladily; Zhuang Zuo; Siok-Bian Ng; Guilin Tang; Shimin Hu; C Cameron Yin; Roberto N Miranda; L Jeffrey Medeiros; Joseph D Khoury
Journal:  J Hematol Oncol       Date:  2015-06-10       Impact factor: 17.388

10.  Extracavitary KSHV-positive solid lymphoma: a large B-cell lymphoma within the spectrum of primary effusion lymphoma.

Authors:  Antonino Carbone; Chiara C Volpi; Dario Caccia; Ambra V Gualeni; Anna M Cilia; Italia Bongarzone; Annunziata Gloghini
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.